Biotherapeutics Cell Line Development Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Transfection & Selection
1.2.3 Single Cell Cloning
1.3 Market by Application
1.3.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biotherapeutics Cell Line Development Market Perspective (2017-2028)
2.2 Biotherapeutics Cell Line Development Growth Trends by Region
2.2.1 Biotherapeutics Cell Line Development Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biotherapeutics Cell Line Development Historic Market Size by Region (2017-2022)
2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Region (2023-2028)
2.3 Biotherapeutics Cell Line Development Market Dynamics
2.3.1 Biotherapeutics Cell Line Development Industry Trends
2.3.2 Biotherapeutics Cell Line Development Market Drivers
2.3.3 Biotherapeutics Cell Line Development Market Challenges
2.3.4 Biotherapeutics Cell Line Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotherapeutics Cell Line Development Players by Revenue
3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2017-2022)
3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2017-2022)
3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2021
3.5 Biotherapeutics Cell Line Development Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
3.7 Date of Enter into Biotherapeutics Cell Line Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotherapeutics Cell Line Development Breakdown Data by Type
4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2017-2022)
4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2023-2028)
5 Biotherapeutics Cell Line Development Breakdown Data by Application
5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2017-2022)
5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biotherapeutics Cell Line Development Market Size (2017-2028)
6.2 North America Biotherapeutics Cell Line Development Market Size by Type
6.2.1 North America Biotherapeutics Cell Line Development Market Size by Type (2017-2022)
6.2.2 North America Biotherapeutics Cell Line Development Market Size by Type (2023-2028)
6.2.3 North America Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
6.3 North America Biotherapeutics Cell Line Development Market Size by Application
6.3.1 North America Biotherapeutics Cell Line Development Market Size by Application (2017-2022)
6.3.2 North America Biotherapeutics Cell Line Development Market Size by Application (2023-2028)
6.3.3 North America Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
6.4 North America Biotherapeutics Cell Line Development Market Size by Country
6.4.1 North America Biotherapeutics Cell Line Development Market Size by Country (2017-2022)
6.4.2 North America Biotherapeutics Cell Line Development Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Market Size (2017-2028)
7.2 Europe Biotherapeutics Cell Line Development Market Size by Type
7.2.1 Europe Biotherapeutics Cell Line Development Market Size by Type (2017-2022)
7.2.2 Europe Biotherapeutics Cell Line Development Market Size by Type (2023-2028)
7.2.3 Europe Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
7.3 Europe Biotherapeutics Cell Line Development Market Size by Application
7.3.1 Europe Biotherapeutics Cell Line Development Market Size by Application (2017-2022)
7.3.2 Europe Biotherapeutics Cell Line Development Market Size by Application (2023-2028)
7.3.3 Europe Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
7.4 Europe Biotherapeutics Cell Line Development Market Size by Country
7.4.1 Europe Biotherapeutics Cell Line Development Market Size by Country (2017-2022)
7.4.2 Europe Biotherapeutics Cell Line Development Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size (2017-2028)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type
8.2.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application
8.3.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
8.4 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region
8.4.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biotherapeutics Cell Line Development Market Size (2017-2028)
9.2 Latin America Biotherapeutics Cell Line Development Market Size by Type
9.2.1 Latin America Biotherapeutics Cell Line Development Market Size by Type (2017-2022)
9.2.2 Latin America Biotherapeutics Cell Line Development Market Size by Type (2023-2028)
9.2.3 Latin America Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
9.3 Latin America Biotherapeutics Cell Line Development Market Size by Application
9.3.1 Latin America Biotherapeutics Cell Line Development Market Size by Application (2017-2022)
9.3.2 Latin America Biotherapeutics Cell Line Development Market Size by Application (2023-2028)
9.3.3 Latin America Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
9.4 Latin America Biotherapeutics Cell Line Development Market Size by Country
9.4.1 Latin America Biotherapeutics Cell Line Development Market Size by Country (2017-2022)
9.4.2 Latin America Biotherapeutics Cell Line Development Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size (2017-2028)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type
10.2.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application
10.3.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
10.4 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country
10.4.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Details
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
11.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.1.5 Becton Dickinson & Company Recent Developments
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
11.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.2.5 Beckman Coulter Recent Developments
11.3 Boehringer Ingelheim Group
11.3.1 Boehringer Ingelheim Group Company Details
11.3.2 Boehringer Ingelheim Group Business Overview
11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
11.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.3.5 Boehringer Ingelheim Group Recent Developments
11.4 Catalent Inc.
11.4.1 Catalent Inc. Company Details
11.4.2 Catalent Inc. Business Overview
11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
11.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.4.5 Catalent Inc. Recent Developments
11.5 CMC Biologics A/S
11.5.1 CMC Biologics A/S Company Details
11.5.2 CMC Biologics A/S Business Overview
11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
11.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.5.5 CMC Biologics A/S Recent Developments
11.6 Lonza Group Ltd.
11.6.1 Lonza Group Ltd. Company Details
11.6.2 Lonza Group Ltd. Business Overview
11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
11.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.6.5 Lonza Group Ltd. Recent Developments
11.7 EMD Millipore
11.7.1 EMD Millipore Company Details
11.7.2 EMD Millipore Business Overview
11.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
11.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.7.5 EMD Millipore Recent Developments
11.8 Partec (Sysmex Corporation)
11.8.1 Partec (Sysmex Corporation) Company Details
11.8.2 Partec (Sysmex Corporation) Business Overview
11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
11.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.8.5 Partec (Sysmex Corporation) Recent Developments
11.9 ProBioGen AG
11.9.1 ProBioGen AG Company Details
11.9.2 ProBioGen AG Business Overview
11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
11.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.9.5 ProBioGen AG Recent Developments
11.10 Selexis SA
11.10.1 Selexis SA Company Details
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
11.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.10.5 Selexis SA Recent Developments
11.11 Sigma-Aldrich Co. LLC.
11.11.1 Sigma-Aldrich Co. LLC. Company Details
11.11.2 Sigma-Aldrich Co. LLC. Business Overview
11.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
11.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.11.5 Sigma-Aldrich Co. LLC. Recent Developments
11.12 Sony Biotechnology Inc.
11.12.1 Sony Biotechnology Inc. Company Details
11.12.2 Sony Biotechnology Inc. Business Overview
11.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
11.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.12.5 Sony Biotechnology Inc. Recent Developments
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.13.5 Thermo Fisher Scientific Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Transfection & Selection
Table 3. Key Players of Single Cell Cloning
Table 4. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Biotherapeutics Cell Line Development Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biotherapeutics Cell Line Development Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Biotherapeutics Cell Line Development Market Share by Region (2017-2022)
Table 8. Global Biotherapeutics Cell Line Development Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Biotherapeutics Cell Line Development Market Share by Region (2023-2028)
Table 10. Biotherapeutics Cell Line Development Market Trends
Table 11. Biotherapeutics Cell Line Development Market Drivers
Table 12. Biotherapeutics Cell Line Development Market Challenges
Table 13. Biotherapeutics Cell Line Development Market Restraints
Table 14. Global Biotherapeutics Cell Line Development Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Biotherapeutics Cell Line Development Revenue Share by Players (2017-2022)
Table 16. Global Top Biotherapeutics Cell Line Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2021)
Table 17. Ranking of Global Top Biotherapeutics Cell Line Development Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Biotherapeutics Cell Line Development Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotherapeutics Cell Line Development Product Solution and Service
Table 21. Date of Enter into Biotherapeutics Cell Line Development Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2022)
Table 25. Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2023-2028)
Table 27. Global Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Biotherapeutics Cell Line Development Revenue Share by Application (2017-2022)
Table 29. Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Biotherapeutics Cell Line Development Revenue Share by Application (2023-2028)
Table 31. North America Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Biotherapeutics Cell Line Development Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Biotherapeutics Cell Line Development Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Biotherapeutics Cell Line Development Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Biotherapeutics Cell Line Development Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Biotherapeutics Cell Line Development Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Biotherapeutics Cell Line Development Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Biotherapeutics Cell Line Development Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Biotherapeutics Cell Line Development Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Biotherapeutics Cell Line Development Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Biotherapeutics Cell Line Development Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Biotherapeutics Cell Line Development Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Biotherapeutics Cell Line Development Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Biotherapeutics Cell Line Development Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Biotherapeutics Cell Line Development Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Biotherapeutics Cell Line Development Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Biotherapeutics Cell Line Development Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Biotherapeutics Cell Line Development Market Size by Country (2023-2028) & (US$ Million)
Table 61. Becton Dickinson & Company Company Details
Table 62. Becton Dickinson & Company Business Overview
Table 63. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 64. Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 65. Becton Dickinson & Company Recent Developments
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 69. Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 70. Beckman Coulter Recent Developments
Table 71. Boehringer Ingelheim Group Company Details
Table 72. Boehringer Ingelheim Group Business Overview
Table 73. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 74. Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 75. Boehringer Ingelheim Group Recent Developments
Table 76. Catalent Inc. Company Details
Table 77. Catalent Inc. Business Overview
Table 78. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 79. Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 80. Catalent Inc. Recent Developments
Table 81. CMC Biologics A/S Company Details
Table 82. CMC Biologics A/S Business Overview
Table 83. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 84. CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 85. CMC Biologics A/S Recent Developments
Table 86. Lonza Group Ltd. Company Details
Table 87. Lonza Group Ltd. Business Overview
Table 88. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 89. Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 90. Lonza Group Ltd. Recent Developments
Table 91. EMD Millipore Company Details
Table 92. EMD Millipore Business Overview
Table 93. EMD Millipore Biotherapeutics Cell Line Development Product
Table 94. EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 95. EMD Millipore Recent Developments
Table 96. Partec (Sysmex Corporation) Company Details
Table 97. Partec (Sysmex Corporation) Business Overview
Table 98. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 99. Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 100. Partec (Sysmex Corporation) Recent Developments
Table 101. ProBioGen AG Company Details
Table 102. ProBioGen AG Business Overview
Table 103. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 104. ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 105. ProBioGen AG Recent Developments
Table 106. Selexis SA Company Details
Table 107. Selexis SA Business Overview
Table 108. Selexis SA Biotherapeutics Cell Line Development Product
Table 109. Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 110. Selexis SA Recent Developments
Table 111. Sigma-Aldrich Co. LLC. Company Details
Table 112. Sigma-Aldrich Co. LLC. Business Overview
Table 113. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 114. Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 115. Sigma-Aldrich Co. LLC. Recent Developments
Table 116. Sony Biotechnology Inc. Company Details
Table 117. Sony Biotechnology Inc. Business Overview
Table 118. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 119. Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 120. Sony Biotechnology Inc. Recent Developments
Table 121. Thermo Fisher Scientific Inc. Company Details
Table 122. Thermo Fisher Scientific Inc. Business Overview
Table 123. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 124. Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 125. Thermo Fisher Scientific Inc. Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Cell Line Development Market Share by Type: 2021 VS 2028
Figure 2. Transfection & Selection Features
Figure 3. Single Cell Cloning Features
Figure 4. Global Biotherapeutics Cell Line Development Market Share by Application: 2021 VS 2028
Figure 5. In-house Case Studies
Figure 6. Outsource Case Studies
Figure 7. Hybrid Case Studies
Figure 8. Do-It-Yourself (DIY) Case Studies
Figure 9. Biotherapeutics Cell Line Development Report Years Considered
Figure 10. Global Biotherapeutics Cell Line Development Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Biotherapeutics Cell Line Development Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Biotherapeutics Cell Line Development Market Share by Region: 2021 VS 2028
Figure 13. Global Biotherapeutics Cell Line Development Market Share by Players in 2021
Figure 14. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2021
Figure 16. North America Biotherapeutics Cell Line Development Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Biotherapeutics Cell Line Development Market Size Market Share by Type (2017-2028)
Figure 18. North America Biotherapeutics Cell Line Development Market Size Market Share by Application (2017-2028)
Figure 19. North America Biotherapeutics Cell Line Development Market Size Share by Country (2017-2028)
Figure 20. United States Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Biotherapeutics Cell Line Development Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Biotherapeutics Cell Line Development Market Size Market Share by Type (2017-2028)
Figure 24. Europe Biotherapeutics Cell Line Development Market Size Market Share by Application (2017-2028)
Figure 25. Europe Biotherapeutics Cell Line Development Market Size Share by Country (2017-2028)
Figure 26. Germany Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Biotherapeutics Cell Line Development Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Biotherapeutics Cell Line Development Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Biotherapeutics Cell Line Development Market Size Share by Region (2017-2028)
Figure 36. China Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Biotherapeutics Cell Line Development Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Biotherapeutics Cell Line Development Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Biotherapeutics Cell Line Development Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Biotherapeutics Cell Line Development Market Size Share by Country (2017-2028)
Figure 46. Mexico Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Biotherapeutics Cell Line Development Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Biotherapeutics Cell Line Development Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Biotherapeutics Cell Line Development Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Biotherapeutics Cell Line Development Market Size Share by Country (2017-2028)
Figure 52. Turkey Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Biotherapeutics Cell Line Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 56. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 57. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 58. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 59. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 60. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 61. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 62. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 63. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 64. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 65. Sigma-Aldrich Co. LLC. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 66. Sony Biotechnology Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 67. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
